Surgical Treatment of Aortic Valve Papillary Fibroelastoma in Combination With Coronary Artery Bypass Grafting
https://doi.org/10.35401/2541-9897-2023-26-3-80-86
Abstract
Objective: To describe a rare case of surgical treatment of aortic valve papillary fibroelastoma in combination with coronary artery bypass grafting.
Clinical case: The patient was hospitalized with a suspected mass on the left coronary cusp of the aortic valve and complained of retrosternal pain that appeared during moderate exertion and brisk walking and went away with rest. The patient history revealed that these clinical manifestations began in February 2022 and were treated by coronary stenting. Since May 2022 the patient noticed symptoms of recurrent angina. Transthoracic echocardiogram dated June 14, 2022 revealed a 13 × 12 mm additional mobile mass on the left coronary cusp. On June 30, 2022 the patient had an open surgery: mass removal, coronary artery bypass grafting of the anterior descending artery, and coronary artery bypass grafting of the circumflex artery. During the aortic valve exploration, the mass was visualized on the left coronary cusp on the side of the left ventricle. The mass was removed by precision marginal excision.
Conclusions: To timely examine patients, refer them for surgical treatment, preserve and prolong their life, and improve its quality, clinical practitioners should know clinical manifestations and challenges in screening for aortic valve papillary fibroelastoma.
About the Authors
S. A. Fedorov
Scientific Research Institute – Specialized Cardiosurgical Clinical Hospital named after Academician B.A. Korolev
Russian Federation
Russian Federation
Sergey A. Fedorov, Cand. Sci. (Med.), Cardiovascular Surgeon
603950
ulitsa Vaneeva 209
Nizhnу Novgorod
S. A. Zhurko
Scientific Research Institute – Specialized Cardiosurgical Clinical Hospital named after Academician B.A. Korolev
Russian Federation
Russian Federation
Sergey A. Zhurko, Cand. Sci. (Med.), Cardiovascular Surgeon
Nizhnу Novgorod
O. R. Shirokova
Scientific Research Institute – Specialized Cardiosurgical Clinical Hospital named after Academician B.A. Korolev
Russian Federation
Russian Federation
Olga R. Shirokova, Cand. Sci. (Med.), Cardiovascular Surgeon
Nizhnу Novgorod
V. V. Radovsky
Nizhny Novgorod Regional Children’s Clinical Hospital
Russian Federation
Russian Federation
Viacheslav V. Radovsky, Pathologist
Nizhny Novgorod
References
1. Basso C, Rizzo S, Valente M, Thiene G. Prevalence and pathology of primary cardiac tumors. Cardiovascular Medicine. 2012;15(01):18–28. doi: 10.4414/cvm.2012.01638
2. Maleszewski JJ, Anavekar NS, Moynihan TJ, Klarich KW. Pathology, imaging, and treatment of cardiac tumours. Nat Rev Cardiol. 2017;14(9):536–549. PMID: 28436488. doi: 10.1038/nrcardio.2017.47
3. Mendes GS, Abecasis J, Ferreira A, et al. Cardiac tumors: three decades of experience from a tertiary center: are we changing diagnostic work-up with new imaging tools?. Cardiovasc Pathol. 2020;49:107242. PMID: 32629212. doi: 10.1016/j.carpath.2020.107242
4. Tamin SS, Maleszewski JJ, Scott CG, et al. Prognostic and bioepidemiologic implications of papillary fibroelastomas. J Am Coll Cardiol. 2015;65(22):2420–2429. PMID: 26046736. doi: 10.1016/j.jacc.2015.03.569
5. Wang JG, Wang B, Hu Y, et al. Clinicopathologic features and outcomes of primary cardiac tumors: a 16-year-experience with 212 patients at a Chinese medical center. Cardiovasc Pathol. 2018;33:45–54. PMID: 29414432. doi: 10.1016/j.carpath.2018.01.003
6. Ngaage DL, Mullany CJ, Daly RC, et al. Surgical treatment of cardiac papillary fibroelastoma: a single center experience with eighty-eight patients. Ann Thorac Surg. 2005;80(5):1712–1718. PMID: 16242444. doi: 10.1016/j.athoracsur.2005.04.030
7. Elbardissi AW, Dearani JA, Daly RC, et al. Survival after resection of primary cardiac tumors: a 48-year experience. Circulation. 2008;118(14 Suppl):S7–S15. PMID: 18824772. doi: 10.1161/CIRCULATIONAHA.107.783126
8. Wu HM, Chen Y, Xiao ZB, et al. Clinical and pathological characteristics of cardiac tumors: analyses of 689 cases at a single medical center. Zhonghua Bing Li Xue Za Zhi. 2019;48(4):293–297. (In Chinese). PMID: 30955265. doi: 10.3760/cma.j.issn.0529-5807.2019.04.006
9. Carney JA, Hruska LS, Beauchamp GD, Gordon H. Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Mayo Clin Proc. 1986;61(3):165–172. PMID: 3945116. doi: 10.1016/s0025-6196(12)61843-6
10. Mankad R, Herrmann J. Cardiac tumors: echo assessment. Echo Res Pract. 2016;3(4):R65–R77. PMID: 27600455. PMCID: PMC5292983. doi: 10.1530/ERP-16-0035
11. Ivanov AS, Baloyan GM, Rodionov AS, et al. Papillary fibroelastoma of the heart. Kardiologiya i Serdechno-Sosudistaya Khirurgiya. 2009;2(4):91–94. (In Russ.).
12. Cresti A, Chiavarelli M, Glauber M, et al. Incidence rate of primary cardiac tumors: a 14-year population study. J Cardiovasc Med (Hagerstown). 2016;17(1):37–43. PMID: 25022931. doi: 10.2459/JCM.0000000000000059
13. Scheffel H, Baumueller S, Stolzmann P, et al. Atrial myxomas and thrombi: comparison of imaging features on CT. AJR Am J Roentgenol. 2009;192(3):639–645. PMID: 19234259. doi: 10.2214/AJR.08.1694
14. Cianciulli TF, Soumoulou JB, Lax JA, et al. Papillary fibroelastoma: clinical and echocardiographic features and initial approach in 54 cases. Echocardiography. 2016;33(12):1811–1817. PMID: 27566126. doi: 10.1111/echo.13351
15. Belov YV, Nechaenko MA, Ivanov VA, Fedorov DN, Kiprensky AY. Diagnostics and surgical tactics for papillary fibroelastomas of the heart. Khirurgiia (Mosk). 2017;(2):10–20. (In Russ.). PMID: 28303868. doi: 10.17116/hirurgia2017210-20
Review
For citations:
Fedorov S.A., Zhurko S.A., Shirokova O.R., Radovsky V.V. Surgical Treatment of Aortic Valve Papillary Fibroelastoma in Combination With Coronary Artery Bypass Grafting. Innovative Medicine of Kuban. 2023;(3):80-86. (In Russ.) https://doi.org/10.35401/2541-9897-2023-26-3-80-86
Views:
414
Email this article 
